TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis
- 31 October 1995
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 31 (11), 1856-1861
- https://doi.org/10.1016/0959-8049(95)00399-4
Abstract
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldAbnormalities in the TP53 tumour suppressor gene were evaluated in 106 unselected breast carcinomas and compared to clinical outcome of the disease. Tumours were screened for p53 abnormalities using immunohistochemical staining and polymerase chain reaction-constant denaturant gel electrophoresis (PCR-CDGE) analysis, followed by PCR and direct sequencing. Allelic loss at the TP53 locus was determined with polymorphic markers by comparing normal and tumour DNA. For approximately half of the patients, abnormal p53 protein expression in serum was determined by an ELISA assay. p53 abnormalities, detected as mutations and/or nuclear staining, were found in 37.6 (38/101) of cases. Nuclear staining for p53 protein could be identified in 33.7% of the tumours. Mutations in exons 5-8 were detected in 18.9% of the tumours, and an association was found between mutations and nuclear staining. Allelic loss in the TP53 region on 17p was more frequent in tumours showing changes in the TP53 gene (72.7%) compared to tumours with no mutation (45.8%). Serum levels of p53 antibodies showed no association with either TP53 mutations or nuclear staining. Women with TP53 mutations in their tumours had an elevated risk of dying during the study period (RR (relative risk) = 3.4, P = 0.014). The effects of p53 positive staining were similar (RR = 3.2, P = 0.013). Considering all abnormalities, mutation and/or staining, the relative risk of dying from breast cancer was 3.5 (P = 0.008)Keywords
This publication has 22 references indexed in Scilit:
- Multifactorial analysis of p53 alteration in human cancer: A reviewInternational Journal of Cancer, 1994
- The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesisBritish Journal of Cancer, 1994
- Amplification of a gene encoding a p53-associated protein in human sarcomasNature, 1992
- Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumoursThe Lancet, 1992
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990
- p53: oncogene or anti-oncogene?Genes & Development, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Detection of antibodies against the cellular protein p53 in sera from patients with breast cancerInternational Journal of Cancer, 1982